Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Ultra High-Frequency Ultrasound and Photoacoustics Enable Breakthrough Molecular Imaging in Translational Research

Abstract:
Designed specifically for preclinical research, ultra high-frequency ultrasound systems enable in vivo viewing and assessment of miniscule targets. When combined with high-resolution molecular imaging, these systems allow researchers to view small-animal anatomical structures and micro-environmental functions in real time, such as beating hearts and growing malignancies.

Ultra High-Frequency Ultrasound and Photoacoustics Enable Breakthrough Molecular Imaging in Translational Research

Toronto, Canada | Posted on September 3rd, 2012

This breakthrough ultrasound technology allows the world's most prestigious pharmaceutical and biotechnology companies, hospitals, and universities to enhance their research capabilities in areas such as translational research, cardiovascular function and disease, cancer, neurobiology, developmental biology, drug development, phenotypic studies, and genetic research, among others.

One company that has established itself as a leader in preclinical, in vivo imaging is VisualSonics, Inc., a wholly owned subsidiary of clinical ultrasound manufacturer SonoSite, Inc., a Fujifilm company. VisualSonics' Vevo® products line includes high-frequency micro-imaging systems (Vevo® 2100 and 770) and a premier photoacoustic imaging platform, the Vevo LAZR*. The Vevo LAZR* has expanded in vivo nanoparticle imaging and microenvironmental research capabilities by simultaneously collecting and displaying high-resolution micro-ultrasound and photoacoustic signals. These systems have found strong utility in advanced preclinical research resulting in over 700 peer-reviewed publications across the globe.

One area where these technologies show particular promise is translational research. Because translational research connects preclinical research at the bench with clinical outcomes at the patients' bedside, the development of research tools that promise and show direct relevance to imaging and quantification of diseases in humans is critical for today's basic science researchers. As the primary and secondary causes of death globally, cardiovascular disease and cancer represent important basic research and clinical research areas, which can be studied in animal models non-invasively in real-time through the use of high-frequency ultrasound. And, using the company's photoacoustic technology for molecular imaging, cancer can be studied in its earliest stages of progression in animal test subjects.


To introduce in vivo high-frequency ultrasound and photoacoustic imaging to researchers and other potential users, VisualSonics has been offering lab visits with top preclinical researchers using these advanced technologies, as well as free webinar presentations by some of the world's most respected authorities on high-resolution micro-imaging.

To register for upcoming webinars, demonstrations, and laboratory visits—or to learn more about ultra high-frequency ultrasound and molecular imaging systems—go to: VisualSonics.com

####

For more information, please click here

Contacts:
3080 Yonge Street Suite 6100, Box 66
Toronto, Ontario, Canada
M4N 3N1
T. +1.416.484.5000
F. +1.416.484.5001
North American Toll Free 1.866.416.4636

SA Perillo

Copyright © VisualSonics Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Industrial Nanotech, Inc. to Publish PCAOB Audited Financials July 31st, 2014

Nanostructured metal-oxide catalyst efficiently converts CO2 to methanol: Highly reactive sites at interface of 2 nanoscale components could help overcome hurdle of using CO2 as a starting point in producing useful products July 31st, 2014

Carnegie Mellon Chemists Create Nanofibers Using Unprecedented New Method July 31st, 2014

Pressure probing potential photoelectronic manufacturing compound July 31st, 2014

Nanomedicine

Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014

New imaging agent provides better picture of the gut July 30th, 2014

Zenosense, Inc. July 29th, 2014

Optimum inertial design for self-propulsion: A new study investigates the effects of small but finite inertia on the propulsion of micro and nano-scale swimming machines July 29th, 2014

Announcements

Industrial Nanotech, Inc. to Publish PCAOB Audited Financials July 31st, 2014

Nanostructured metal-oxide catalyst efficiently converts CO2 to methanol: Highly reactive sites at interface of 2 nanoscale components could help overcome hurdle of using CO2 as a starting point in producing useful products July 31st, 2014

Carnegie Mellon Chemists Create Nanofibers Using Unprecedented New Method July 31st, 2014

Pressure probing potential photoelectronic manufacturing compound July 31st, 2014

Tools

Carnegie Mellon Chemists Create Nanofibers Using Unprecedented New Method July 31st, 2014

New imaging agent provides better picture of the gut July 30th, 2014

Nanometrics Reports Second Quarter 2014 Financial Results July 30th, 2014

New Objective Focusing Nanopositioner from nPoint July 30th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE